Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol 4, No 3) Altering the Mitochondrial Genome: Is it Just a Technical Issue? [Book Review]

Cambridge Quarterly of Healthcare Ethics 8 (3):369-374 (1999)
  Copy   BIBTEX

Abstract

Technical, ethical, and social questions of germ-line gene interventions have been widely discussed in the literature. The majority of these discussions focus on planned interventions executed on the nuclear DNA (nDNA). However, human cells also contain another set of genes that is the mitochondrial DNA (mtDNA). As the characteristics of the mtDNA grossly differ from those of nDNA, so do the social, ethical, psychological, and safety considerations of possible interventions on this part of the genetic substance

Categories

Keywords

Reprint years

DOI

10.1017/s096318019900314x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman. [REVIEW]Helen Watt - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (1):88-96.
Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation.Donald S. Rubenstein, David C. Thomasma, Eric A. Schon & Michael J. Zinaman - 1995 - Cambridge Quarterly of Healthcare Ethics 4 (3):316.
Responses and Dialogue: Response to “Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman. [REVIEW]Matthew D. Bacchetta & Gerd Richter - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):450.
Ethical questions in human germ-line gene therapy.Imre Szebik - unknown
Interventions in the human genome: Some moral and ethical considerations.Gerd Richter & Matthew D. Bacchetta - 1998 - Journal of Medicine and Philosophy 23 (3):303 – 317.
Should we change the human genome?Torbjörn Tännsjö - 1993 - Theoretical Medicine and Bioethics 14 (3).
Commentary: How do we think about the ethics of human germ-line genetic therapy?Kathleen Nolan - 1991 - Journal of Medicine and Philosophy 16 (6):613-619.
Germ-line Gene therapy and the clinical ethos of medical Genetics.Gregory Fowler, Eric T. Juengst & Burke K. Zimmerman - 1989 - Theoretical Medicine and Bioethics 10 (2).
Mutated mtDNA distribution in exponentially growing cell cultures and how the segregation rate is increased by the mitochondrial compartments.Christine Reder - 2001 - Acta Biotheoretica 49 (4):235-245.
Response to “Dimensions and Classification of Genetic Interventions in the Human Genome” by Matthew D. Bacchetta and Gerd Richter. [REVIEW]Donald S. Rubenstein - 1998 - Cambridge Quarterly of Healthcare Ethics 7 (1):90-93.
Ethical issues in manipulating the human germ line.Marc Lappé - 1991 - Journal of Medicine and Philosophy 16 (6):621-639.
Human germ-line therapy: The case for its development and use.Burke K. Zimmerman - 1991 - Journal of Medicine and Philosophy 16 (6):593-612.
Debunking the slippery slope argument against human germ-line Gene therapy.David Resnik - 1994 - Journal of Medicine and Philosophy 19 (1):23-40.
Germ-line enhancement of humans and nonhumans.J. Robert Loftis - 2005 - Kennedy Institute of Ethics Journal 15 (1):57-76.

Analytics

Added to PP
2010-08-24

Downloads
34 (#445,975)

6 months
8 (#292,366)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references